118 results
CORRESP
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
11 May 22
Correspondence with SEC
12:00am
to perform an IFRS to GAAP reconciliation:
Research and Development costs
Taxes
Leases
Defined benefit plans
Impairments
Provisions
Hedging
424B2
BIO
Bio-Rad Laboratories Inc. - Ordinary Shares
25 Feb 22
Prospectus for primary offering
12:00am
securities trading, commercial and investment banking, financial advisory, investment management, investment research, principal investment, hedging
424B5
7mxwl0d 61l
23 Feb 22
Prospectus supplement for primary offering
8:40am